The Covid-19 Crisis and Corporate Governance
18 months ago, Monash Law School participated in a major 24 hour global conference on 'The Covid-19 Crisis and its Aftermath: Corporate Governance Implications and Policy Challenges', which was convened by the European Corporate Governance Institute (ECGI) and the Global Corporate Governance Colloquia (GCGC). Other participating academic institutions included the University of Oxford, Columbia Law School, Harvard Law School, Stanford University, University of Tokyo, National University of Singapore, Peking University, Tel Aviv University and Goethe University Frankfurt.
Monash Law School hosted two Panels with leading Australian experts and business people, who examined the health and economic implications of the crisis and its impact on boards of directors.
These Panel Discussions has never been more critical than now, when, in spite of mass vaccination, Omicron threatens to seriously disrupt the Australian economy and health system and Federal and State governments seek to find effective policies for economic stability and ‘living with the virus’.
Monash Law School’s Panel Discussions on Covid-19 and corporate governance are available here.
Speakers at each of the Panel sessions are as follows:
Panel 1: The differential health, economic and financial effects of the COVID-19 crisis
Moderator: Professor Jennifer Hill (Monash University and ECGI)
Dr Malcolm Edey, Adjunct Professor of Economics, The University of Sydney; former Assistant Governor, Reserve Bank of Australia, Chair of the OECD Financial Markets Committee and member of the Basel Committee on Banking Supervision.
John Laker, Chair, ING Australia; member of the Experts Panel of the International Monetary Fund (IMF); former Chair, Australian Prudential Regulation Authority (APRA)
Diana Nicholson, Partner, King & Wood Mallesons
Professor Stephen Turner, Co-Head of Infection and Immunity Program; Head of Microbiology at the Monash Biomedicine Discovery Institute
Panel 2: The impact of the COVID-19 crisis on boards of directors and regulators
Moderator: Jennifer Hill (Monash University and ECGI)
Priscilla Bryans, Partner, Herbert Smith Freehills
Sylvia Falzon, Non-executive director, Suncorp Group, Regis Healthcare and Premier Investments Ltd
Kevin McCann, Chair, Telix Pharmaceuticals Ltd; former Chair, Macquarie Bank
John Price, then-Commissioner, Australian Securities and Investments Commission (ASIC)